Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC16 as a Severity Marker in Acute Bronchiolitis
NCT02984046Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2015
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Serum CC16 rate at Day 1. Status: unknown.
Beyond the preview
Go deeper on NCT02984046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984046.